Richard L. Cassin | Editor at large
Richard L. Cassin is the founder of the FCPA Blog. He serves as editor at large.
He has been named multiple times as one of the 100 Most Influential People In Business Ethics by Ethisphere Magazine. He was named a Trust Across America 2019 Top Thought Leader in Trust.
Cassin’s articles about corruption and compliance have appeared in the Wall Street Journal, Financial Times, Business Times (Singapore), New England Law Review, and many other leading publications. His opinions about FCPA enforcement have been cited recently by the New York Times, Wall Street Journal, Washington Post, Business Week, Variety, Bloomberg’s news wire, Reuters, NPR, Fox News, CNN, and others.
He was a senior partner in a major international law firm and the head of its Asia practice.
Recent Posts
At Large: In Germany, a weird tolerance for corporate crime
For at least ten years, Germany’s financial regulator heard detailed complaints from reliable sources about a $2 billion accounting fraud at Wirecard AG but failed
At Large: Why didn’t Novartis try to conceal its ongoing bribery?
I’m not defending what Novartis did or trying to find an excuse for the company. It violated the FCPA, and (along with a former subsidiary)
More compliance guidance from OFAC, via an enforcement action
The U.S. Treasury Department’s Office of Foreign Assets Control used a settlement agreement Thursday to set out management’s role in creating and running an effective
UK imposes first ‘Magnitsky sanctions’; here’s the list
The UK used its new Magnitsky-style law for the first time last week to sanction 47 individuals and two organizations for their alleged involvement in
At Large: Are you helping someone ‘talk smart’?
This week I’m answering a question from a reader. She asked: “I’ve just started my first job at a big law firm, and I want
Here’s everything new in the Second Edition of the FCPA Resource Guide
The DOJ and SEC published the Second Edition of A Resource Guide to the U.S. Foreign Corrupt Practices Act Friday, updating for the first time
Alexion Pharmaceuticals pays SEC $21.4 million to resolve FCPA offenses
Connecticut-based Alexion Pharmaceuticals, Inc. agreed to pay $21.4 million to resolve SEC charges that the company violated the FCPA by bribing foreign officials in Turkey
At Large: Has the ‘mother of all corporate risks’ finally arrived?
The market for directors and officers liability insurance has been out of kilter since the start of the year, with more demand than supply. Now,
At Large: Five reasons why compliance professionals should read ‘Risk Factors’
Compliance is all about risk — learning to see it, and how to manage it. One way to learn more about risk is by reading
At Large: It’s party time for SEC whistleblowers. Is the Supreme Court about to spoil the fun?
This year the SEC has already awarded $114 million to whistleblowers, nearly twice the amount than for all of 2019. Three awards in 2020 are